Course Identification

Introduction to Drug Discovery in Academia
20253392

Lecturers and Teaching Assistants

Dr. Haim Michael Barr, Dr. Silvia Carvalho, Dr. Alexander Plotnikov, Dr. Noga Kozer, Ms. Galit Cohen, Dr. Khriesto Shurrush, Dr. Noa Lahav , Dr. Leonardo Solmesky, Dr. Gabriel Amitai, Dr. Ronen Gabizon, Dr. Orly Dym
N/A

Course Schedule and Location

2025
Second Semester
10:00 - 16:30
02/04/2025
10/04/2025
46

Field of Study, Course Type and Credit Points

Life Sciences: Laboratory; Elective; 1.00 points
Life Sciences (Brain Sciences: Systems, Computational and Cognitive Neuroscience Track): Laboratory; 1.00 points

Comments

The course will take place at GINCPM ? drug discovery unit
This course will be held in person only

Prerequisites

No

Restrictions

20

Language of Instruction

English

Attendance and participation

Obligatory

Grade Type

Numerical (out of 100)

Grade Breakdown (in %)

40%
60%

Evaluation Type

Seminar

Scheduled date 1

N/A
N/A
-
N/A

Estimated Weekly Independent Workload (in hours)

6

Syllabus

Introduction drug discovery

Guidelines for assays, screening methods

General concepts for biochemical and cell-based assays.

Target identification

Phenotypic vs targeted drug discovery

Lab exercises for proteases and viability screening

Structure-guided hit optimization

Basic medicinal chemistry

Emerging strategies in drug discovery

Covalent targeting

Degraders

Molecular glues

Methods for confirming target engagement by small moecules

ADME-Tox assays (e.g. cell viability, apoptosis, cardiotoxicity and mitochondrial toxicity).

Practical Training Sessions

Discovery team exercise

Project proposal

Participants will experience hands-on training sessions using experimental methods to provide a foundation for applying in-vitro approaches in drug discovery.

The course takes place at the INCPM, drug discovery facility.

 

Learning Outcomes

During the course, students will learn about principles, methods and goals of drug discovery as it pertains to driving academic research towards applications relevant to the clinic. The scope of the course will be limited to small molecules and their use as chemical probes or leads to novel drugs. Students will perform different types of the experiments demonstrating assay development and screening methods, and will practice interpreting their data. Lectures will provide background for lab experiments and broader knowledge of strategies such as phenotypic screening, degraders, covalent targeting, pre-clinical pharmokinetics and pharmacology. Data sharing and multidisciplinary team-work is central to drug discovery, so students will perform a team-based exercise using open-source data from an antiviral discovery campaign. Finally, students will present project proposals for review in a group exercise.

 

Reading List

N/A

Website

N/A